Peng Liang
Presidente presso CLOVER BIOPHARMACEUTICALS, LTD.
Patrimonio netto: 11 M $ in data 31/05/2024
Profilo
Peng Liang is the founder of Sichuan Clover Biopharmaceuticals, Inc. (founded in 2007) and GenHunter Corp.
(founded in 1992).
He is currently the Chairman of Clover Biopharmaceuticals Ltd., Zhejiang Clover Biopharmaceutical, Inc., Director of Clover Biopharmaceuticals Aus Pty Ltd., Director of Clover Biopharmaceuticals Hong Kong Ltd., and President & Treasurer of Clover Biopharmaceuticals USA, Inc. He previously held the position of Associate Professor at Vanderbilt University from 2008 to 2009.
Dr. Liang received his undergraduate degree from Peking University in 1982 and his doctorate from the University of Illinois in 1990.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2024 | 209 702 153 ( 16.17% ) | 11 M $ | 31/05/2024 |
Posizioni attive di Peng Liang
| Società | Posizione | Inizio |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Presidente | 31/10/2018 |
| Clover Biopharmaceuticals Aus Pty Ltd. | Direttore/Membro del Consiglio | 01/06/2017 |
| Clover Biopharmaceuticals USA, Inc. | Presidente | 01/04/2020 |
| Zhejiang Clover Biopharmaceutical, Inc. | Presidente | 01/08/2016 |
| Clover Biopharmaceuticals Hong Kong Ltd. | Direttore/Membro del Consiglio | 01/11/2018 |
Precedenti posizioni note di Peng Liang
| Società | Posizione | Fine |
|---|---|---|
| Vanderbilt University | Corporate Officer/Principal | 01/06/2009 |
Sichuan Clover Biopharmaceuticals, Inc
 Sichuan Clover Biopharmaceuticals, Inc Pharmaceuticals: MajorHealth Technology Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016. | Fondatore | - |
| GenHunter Corp. | Fondatore | - |
Formazione di Peng Liang
| Peking University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Aziende private | 6 |
|---|---|
Sichuan Clover Biopharmaceuticals, Inc
Sichuan Clover Biopharmaceuticals, Inc Pharmaceuticals: MajorHealth Technology Sichuan Clover Biopharmaceuticals, Inc is a clinical-stage biotechnology company based in Chengdu, China. Clover Biopharmaceuticals' mission is to leverage their trimer-tag technology and in-house manufacturing capabilities to develop and deliver innovative and affordable medical solutions. The Chinese company is committed to partnering with leading healthcare organizations to advance their breakthrough pipeline programs and deliver them to patients. The company's pipeline includes many vaccine and therapeutic candidates for the treatment of infectious disease, cancer, and autoimmune disease, created using trimer-tag platform technology. The company was founded in 2007 by Peng Liang, and Joshua Liang has been the CEO of the company since 2016. | Health Technology |
| GenHunter Corp. | |
| Clover Biopharmaceuticals USA, Inc. | |
| Zhejiang Clover Biopharmaceutical, Inc. | |
| Clover Biopharmaceuticals Aus Pty Ltd. | |
| Clover Biopharmaceuticals Hong Kong Ltd. |
- Borsa valori
- Insiders
- Peng Liang
